Moderate delays safe in treating colon cancer

by Paul Mayne,University of Western OntarioSchulich School of Medicine & Dentistry medical resident Dr. Kerollos Wanis, left, assists Drs. David Bottoni and Robert Black with a cancer-resect

Updated on: April 09,2024

Moderate delays safe in treating colon cancer

by Paul Mayne,University of Western OntarioSchulich School of Medicine & Dentistry medical resident Dr. Kerollos Wanis, left, assists Drs. David Bottoni and Robert Black with a cancer-resect

Updated on:April 09,2024

Researchers find genetic pathways to individualized treatment for advanced prostate cancer

by Mayo ClinicCredit: Mayo ClinicResearchers at Mayo Clinic Center for Individualized Medicine have uncovered genetic clues to why tumors resist a specific therapy used for treating advanced pros

Updated on: June 15,2024

Researchers find genetic pathways to individualized treatment for advanced prostate cancer

by Mayo ClinicCredit: Mayo ClinicResearchers at Mayo Clinic Center for Individualized Medicine have uncovered genetic clues to why tumors resist a specific therapy used for treating advanced pros

Updated on:June 15,2024

Researchers develop new one-two punch against melanoma in mouse model

by Johns Hopkins University School of MedicineCredit: Kimmel Cancer CenterResearchers at the Bloomberg~Kimmel Institute for Cancer Immunotherapy at Johns Hopkins and the Johns Hopkins University

Updated on: June 04,2024

Researchers develop new one-two punch against melanoma in mouse model

by Johns Hopkins University School of MedicineCredit: Kimmel Cancer CenterResearchers at the Bloomberg~Kimmel Institute for Cancer Immunotherapy at Johns Hopkins and the Johns Hopkins University

Updated on:June 04,2024

Second primary malignancy risk increased after cutaneous B-cell lymphoma

by Elana GotkinePatients with primary cutaneous B-cell lymphomas (PCBCLs) have an increased risk for second primary malignancies (SPMs), according to a studypublishedonline March 19 in the

Updated on: April 06,2024

Second primary malignancy risk increased after cutaneous B-cell lymphoma

by Elana GotkinePatients with primary cutaneous B-cell lymphomas (PCBCLs) have an increased risk for second primary malignancies (SPMs), according to a studypublishedonline March 19 in the

Updated on:April 06,2024

Researchers exploit DNA amplification in cancer to halt chemoresistance

by Stony Brook UniversityGábor Balázsi, in his Biomedical Engineering laboratory with Rafal Krzysztoń, PhD, and Yiming Wan, PhD, both first co-authors on thePNASpaper. Credit: John Gr

Updated on: June 08,2024

Researchers exploit DNA amplification in cancer to halt chemoresistance

by Stony Brook UniversityGábor Balázsi, in his Biomedical Engineering laboratory with Rafal Krzysztoń, PhD, and Yiming Wan, PhD, both first co-authors on thePNASpaper. Credit: John Gr

Updated on:June 08,2024

Study could explain link between high-cholesterol diet and colon cancer

by University of California, Los AngelesA pale-blue stain shows stem cells multiplying in a mouse's intestine. Credit: Tontonoz lab/UCLANew UCLA research could help explain the link between a

Updated on: June 28,2024

Study could explain link between high-cholesterol diet and colon cancer

by University of California, Los AngelesA pale-blue stain shows stem cells multiplying in a mouse's intestine. Credit: Tontonoz lab/UCLANew UCLA research could help explain the link between a

Updated on:June 28,2024

Advanced ovarian cancer drug gets initial 'no' for NHS in England

by Cancer Research UKCC0 Public domainA targeted drug with potential to slow the progress of ovarian cancer has been rejected for use on the NHS in England.In making its provisional decision on r

Updated on: March 06,2024

Advanced ovarian cancer drug gets initial 'no' for NHS in England

by Cancer Research UKCC0 Public domainA targeted drug with potential to slow the progress of ovarian cancer has been rejected for use on the NHS in England.In making its provisional decision on r

Updated on:March 06,2024

Virus-targeting white blood cells in tumors offer intriguing insights into responsiveness to immunotherapy

by Agency for Science, Technology and Research (A*STAR), SingaporeGreen and red tumor-infiltrating lymphocytes expressing CD39 in human lung cancer. Credit: A*STAR Singapore Immunology NetworkBys

Updated on: March 06,2024

Virus-targeting white blood cells in tumors offer intriguing insights into responsiveness to immunotherapy

by Agency for Science, Technology and Research (A*STAR), SingaporeGreen and red tumor-infiltrating lymphocytes expressing CD39 in human lung cancer. Credit: A*STAR Singapore Immunology NetworkBys

Updated on:March 06,2024

Doctors must stop misleading women about cervical screening

by James Dickinson,The ConversationCredit: AI-generated imageCervical screening is one of the most effective screening tests, responsible for substantial reduction in death from cervical cancer.

Updated on: May 17,2024

Doctors must stop misleading women about cervical screening

by James Dickinson,The ConversationCredit: AI-generated imageCervical screening is one of the most effective screening tests, responsible for substantial reduction in death from cervical cancer.

Updated on:May 17,2024

Precision oncology insights revealed for colorectal cancer

by UNC Lineberger Comprehensive Cancer CenterCredit: CC0 Public DomainNext-generation sequencing of tumor DNA from patients with colorectal cancer revealed genetic alterations that were linked to

Updated on: March 12,2024

Precision oncology insights revealed for colorectal cancer

by UNC Lineberger Comprehensive Cancer CenterCredit: CC0 Public DomainNext-generation sequencing of tumor DNA from patients with colorectal cancer revealed genetic alterations that were linked to

Updated on:March 12,2024

Predicting the risk of cancer with computational electrodynamics

by Nils Heinonen,Argonne National LaboratoryAlterations of the nanoscale structure of live HeLa cells after chemical fixation, as observed using partial wave spectroscopic (PWS) optical microsco

Updated on: May 11,2024

Predicting the risk of cancer with computational electrodynamics

by Nils Heinonen,Argonne National LaboratoryAlterations of the nanoscale structure of live HeLa cells after chemical fixation, as observed using partial wave spectroscopic (PWS) optical microsco

Updated on:May 11,2024

First randomized phase 3 clinical trial of neoadjuvant immunotherapy in patients with kidney cancer

by ECOG-ACRIN Cancer Research GroupCredit: Pixabay/CC0 Public DomainThe ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) will present data from PROSPER RCC (EA8143), the first randomized phase 3 trial of

Updated on: January 04,2024

First randomized phase 3 clinical trial of neoadjuvant immunotherapy in patients with kidney cancer

by ECOG-ACRIN Cancer Research GroupCredit: Pixabay/CC0 Public DomainThe ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) will present data from PROSPER RCC (EA8143), the first randomized phase 3 trial of

Updated on:January 04,2024